Open AccessAnti-anxiety effect of a novel 5-HT3receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice
Author(s) -
Yeshwant Kurhe,
Radhakrishnan Mahesh,
Thangaraj Devadoss,
Deepali Gupta
Publication year - 2014
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.125186
Subject(s) - antagonist , open field , elevated plus maze , receptor antagonist , chemistry , receptor , endocrinology , medicine , anxiety , pharmacology , psychiatry
To investigate the anti-anxiety activity of "6k", a novel 5-hydroxytryptamine type 3 (5-HT₃) receptor antagonist in in mice.